Antiphospholipid and anti-oxidized LDL (anti-oxLDL) antibodies are associated with
thrombosis and atherosclerosis. Rheumatoid arthritis (RA) is characterized by excess …

Objective. To determine the prevalence of preclinical vascular disease and associated risk
factors in patients with systemic lupus erythematosus (SLE) or primary antiphospholipid …

Background Programmed cell death protein 1 (PD-1) plays an important role in immune
response regulation as a co-inhibitory signal during T cell activation. However, there is little …

Atherosclerosis is an inflammatory condition characterised by an abundance of activated
immunocompetent cells in plaques which cause cardiovascular disease (CVD) when they …

It has been demonstrated that atherosclerosis (ATS) is enhanced in autoimmune rheumatic
diseases, such as systemic lupus erythematosus (SLE). The reason for this accelerated …

Published data were reviewed to evaluate the occurrence of antiphospholipid antibodies
(aPL) in rheumatoid arthritis (RA) patients and to investigate their clinical relevance in this …

Objectives Heart valve lesions and central nervous system (CNS) involvement are among
the most common manifestations of antiphospholipid syndrome (APS). We evaluated …

Background Oxylipins are biological lipids that have been implicated in inflammation. We
previously found that certain oxylipins correlated with clinical manifestations in psoriatic …

Objective To analyze the association of antiphospholipid antibodies (aPL) with the
development of clinical thrombotic manifestations and to characterize the efficacy of anti …

Background Despite expansion in the 2006 Sydney antiphospholipid syndrome (APS)
classification criteria to include IgG/IgM anti-β2-glycoprotein (aβ2GPI) antibodies in addition …